Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

68.82 +0.72 (+1.06%)

Streaming Delayed Price Updated: 1:15 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Focus On High Cash Flow Companies. You Are The Company You Keep. ↗

January 05, 2025

There are too many stocks acting well to expect a bear market right now.

Via Talk Markets

Topics Stocks / Equities

Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly ↗

January 04, 2025

Energy plays, a biotech and a brokerage also are flashing buy signals or setting up.

Via Investor's Business Daily

Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday ↗

January 03, 2025

US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection & UDR report strong quarters.

Via Benzinga

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

January 02, 2025

From GeneDx

Via Business Wire

Best Performing Stocks Of 2024 ↗

January 02, 2025

A look at the some of best performing stocks in 2024 of current Russell 3,000 members.

Via Talk Markets

Topics Stocks / Equities

Why NASDAQ:WGS qualifies as a high growth stock. ↗

December 11, 2024

Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS).

Via Chartmill

The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts ↗

October 16, 2024

Via Benzinga

GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics ↗

September 19, 2024

The company provides sequencing tools to help diagnose children with rare diseases.

Via Investor's Business Daily

The Top 5 Mid Cap Stocks Of 2024 ↗

December 19, 2024

These high-fliers are on the leading edge of innovation.

Via Talk Markets

Topics Stocks / Equities

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 16, 2024

From GeneDx

Via Business Wire

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

December 05, 2024

From GeneDx

Via Business Wire

GeneDx to Participate in Upcoming Investor Conference

November 22, 2024

From GeneDx

Via Business Wire

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

November 19, 2024

From GeneDx

Via Business Wire

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary

November 18, 2024

From GeneDx

Via Business Wire

Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year ↗

November 16, 2024

Via The Motley Fool

Don’t Confuse Brains With A Bull Market, Or Price With Value ↗

November 10, 2024

If you are interested in the stock market, maybe it is time to stop focusing on The Fed.

Via Talk Markets

New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields

November 07, 2024

From GeneDx

Via Business Wire

GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

November 04, 2024

From GeneDx

Via Business Wire

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? ↗

November 03, 2024

Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).

Via Benzinga

Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results ↗

October 29, 2024

Via Benzinga

Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views ↗

October 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 29, 2024

Via Benzinga

Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance ↗

October 29, 2024

GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue.

Via Benzinga

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗

October 29, 2024

Via Benzinga

GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

October 29, 2024

From GeneDx

Via Business Wire

Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening

October 24, 2024

From GeneDx

Via Business Wire

GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns

October 08, 2024

From GeneDx

Via Business Wire

GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

October 03, 2024

From GeneDx

Via Business Wire

The Markets Are Ignoring Risk, But That Does Not Mean You Should... ↗

September 29, 2024

It is Fall clean-up time. Sell lagging and sagging companies.

Via Talk Markets

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 27, 2024

From GeneDx

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.